What is Brucellosis Vaccines - Global Market?
The Brucellosis Vaccines - Global Market is a specialized sector that focuses on the production and distribution of vaccines used to prevent Brucellosis, a bacterial infection that affects various animals and can be transmitted to humans. These vaccines are crucial in maintaining the health of livestock and preventing the spread of the disease. The global market for these vaccines is vast and diverse, encompassing various types of vaccines and applications across different species of animals. Two of the most commonly used vaccines in this market are the S19 Vaccine and the RB51 Vaccine Strain. The S19 Vaccine, derived from a strain of Brucella abortus, is primarily used in cattle. It has been proven effective in preventing Brucellosis in this species, contributing significantly to the overall market value. On the other hand, the RB51 Vaccine Strain, a rough strain of Brucella abortus, is used in both cattle and sheep. This vaccine is known for its safety and efficacy, making it a popular choice in the market. Both these vaccines play a crucial role in the global Brucellosis Vaccines market, contributing to its growth and development.
S19 Vaccine, RB51 Vaccine Strain in the Brucellosis Vaccines - Global Market:
The Brucellosis Vaccines - Global Market is not limited to cattle. It also extends to sheep and other animals susceptible to Brucellosis. The use of these vaccines in cattle is widespread, given the high susceptibility of this species to the disease. Vaccination helps in maintaining the health of the herd and preventing economic losses due to disease outbreaks. In sheep, the use of Brucellosis vaccines is also common. The disease can cause significant losses in sheep farming, making vaccination a necessary preventive measure. The "others" category in this market includes various other animals like goats, pigs, and dogs. The use of Brucellosis vaccines in these animals is less common but still contributes to the overall market.
Cattle, Sheep, Others in the Brucellosis Vaccines - Global Market:
The global Brucellosis Vaccines market, as of 2022, was valued at US$ 11 million. It is projected to grow to US$ 14 million by 2029, marking a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period of 2023-2029. This growth is driven by the increasing demand for these vaccines and the ongoing efforts to prevent and control Brucellosis. The market is dominated by the top four manufacturers, who collectively hold a share of over 35%. China stands as the largest market for Brucellosis Vaccines, accounting for about 30% of the global market. This can be attributed to the large livestock population in the country and the high prevalence of Brucellosis.
| Report Metric | Details |
| Report Name | Brucellosis Vaccines - Market |
| Forecasted market size in 2029 | US$ 14 million |
| CAGR | 3.7% |
| Forecasted years | 2023 - 2029 |
| Global Brucellosis Vaccines market, by region: |
|
| Global Brucellosis Vaccines market, Segment by Type: |
|
| Global Brucellosis Vaccines market, by Application |
|
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
